These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15662503)

  • 1. [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation].
    Gabel-Pfisterer A; Wehner A; Heimann H; Foerster MH; Wachtlin J
    Ophthalmologe; 2005 Jun; 102(6):592-6. PubMed ID: 15662503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV.
    Wachtlin J; Stroux A; Wehner A; Heimann H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):438-45. PubMed ID: 15672299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
    Keam SJ; Scott LJ; Curran MP
    Drugs; 2003; 63(22):2521-54. PubMed ID: 14609361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2003; 47(6):595-8. PubMed ID: 14636851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.
    Gelisken F; Inhoffen W; Karim-Zoda K; Grisanti S; Partsch M; Voelker M; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2005 Mar; 243(3):198-203. PubMed ID: 15258778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F; Goeminne P
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration.
    Haddad WM; Coscas G; Soubrane G
    Br J Ophthalmol; 2002 Jun; 86(6):663-9. PubMed ID: 12034690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Mori R; Kelkar A; De Laey JJ
    Bull Soc Belge Ophtalmol; 2006; (299):57-64. PubMed ID: 16681088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H; Gierek-Łapińska A
    Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation.
    Harding S
    Eye (Lond); 2001 Jun; 15(Pt 3):407-12. PubMed ID: 11450766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.
    Gelisken F; Lafaut BA; Inhoffen W; Voelker M; Grisanti S; Bartz-Schmidt KU
    Br J Ophthalmol; 2004 Feb; 88(2):207-11. PubMed ID: 14736776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.